APO-GO sol inj 30 mg/3ml pen 3 ml
7680631750043
CH-63175
N04BC07
01.08.0.
Reimbursement limitations:
APOGOPEN
Après demande de prise en charge auprès de la caisse maladie suite à la consultation …
1 / 3
google
Details
- Product number
- 6317501
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- apomorphini hydrochloridum hemihydricum 10 mg, E 223 1.37 mg corresp. natrium 0.33 mg, acidum hydrochloricum q.s. ad pH, aqua ad iniectabilia ad solutionem pro 1 ml.
Articles (1)
APO-go 10 mg/ml, Injektionslösung in einem Pen
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1.37 MG | Substance | HBESI |
|
(N/A)
|
0.33 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 63175
- Drug name
- APO-go 10 mg/ml, Injektionslösung in einem Pen
- Galenic form
- INLFP
- ATC Code
- N04BC07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/10/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 01.08.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- APO-GO sol inj 30 mg/3ml pen 3 ml
- Description (DE)
- APO-GO Inj Lös 30 mg/3ml Pen 3 ml
- Market launch
- 07/10/2015
- Narcotic (BTM)
- No